New

NexCAR19 CAR-T Therapy

  • President Draupadi Murmu launched the country's first indigenous anti-cancer CAR-T cell therapy NexCAR19.
  • It has been prepared jointly by IIT Bombay and Tata Memorial Centre.
  • This therapy is a form of immunotherapy and gene therapy.
    • In this, T cells (immune cells) are made stronger.
    • These T-cells attack cancer cells.
  • This treatment will be comparatively very cheap in India.
    • The cost of this treatment abroad is approximately ₹ 4 crore.
    • This treatment will be possible in India for approximately ₹ 30 lakh.

Related Articles

'Moidams' included in UNESCO World Heritage List
Model Skill Loan Scheme
Henley & Partners Passport Ranking
H 125 Helicopter
65th International Maths Olympiad Competition
Gross Environmental Product (GEP) Index
« »
  • SUN
  • MON
  • TUE
  • WED
  • THU
  • FRI
  • SAT
Have any Query?

Our support team will be happy to assist you!

+91-9555 124 124
info@sanskritiias.com
OR